Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs CORAL LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA CORAL LAB. BAL PHARMA/
CORAL LAB.
 
P/E (TTM) x 40.8 14.6 280.3% View Chart
P/BV x 2.3 0.9 263.8% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 BAL PHARMA   CORAL LAB.
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
CORAL LAB.
Mar-23
BAL PHARMA/
CORAL LAB.
5-Yr Chart
Click to enlarge
High Rs134368 36.4%   
Low Rs63217 29.2%   
Sales per share (Unadj.) Rs193.9218.8 88.6%  
Earnings per share (Unadj.) Rs1.718.1 9.2%  
Cash flow per share (Unadj.) Rs7.524.2 31.0%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs40.7433.6 9.4%  
Shares outstanding (eoy) m15.693.57 439.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.51.3 38.1%   
Avg P/E ratio x59.216.2 364.9%  
P/CF ratio (eoy) x13.212.1 108.9%  
Price / Book Value ratio x2.40.7 359.8%  
Dividend payout %59.90-   
Avg Mkt Cap Rs m1,5491,045 148.3%   
No. of employees `000NANA-   
Total wages/salary Rs m553111 496.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,042781 389.4%  
Other income Rs m969 13.6%   
Total revenues Rs m3,052850 358.9%   
Gross profit Rs m25339 655.8%  
Depreciation Rs m9122 418.7%   
Interest Rs m1233 3,632.4%   
Profit before tax Rs m4782 57.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2118 119.5%   
Profit after tax Rs m2664 40.6%  
Gross profit margin %8.34.9 168.4%  
Effective tax rate %44.821.6 207.1%   
Net profit margin %0.98.3 10.4%  
BALANCE SHEET DATA
Current assets Rs m2,2821,235 184.7%   
Current liabilities Rs m2,093119 1,765.0%   
Net working cap to sales %6.2143.0 4.3%  
Current ratio x1.110.4 10.5%  
Inventory Days Days8231 3.3%  
Debtors Days Days1,1281,094 103.0%  
Net fixed assets Rs m829508 163.1%   
Share capital Rs m15736 439.1%   
"Free" reserves Rs m4811,512 31.8%   
Net worth Rs m6381,548 41.2%   
Long term debt Rs m3050-   
Total assets Rs m3,1101,743 178.4%  
Interest coverage x1.425.3 5.5%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.00.4 218.3%   
Return on assets %4.83.9 123.4%  
Return on equity %4.14.2 98.6%  
Return on capital %18.15.5 327.0%  
Exports to sales %66.492.1 72.1%   
Imports to sales %22.40-   
Exports (fob) Rs m2,020719 280.9%   
Imports (cif) Rs m683NA-   
Fx inflow Rs m2,020719 280.9%   
Fx outflow Rs m71613 5,369.5%   
Net fx Rs m1,305706 184.8%   
CASH FLOW
From Operations Rs m-18127 -14.6%  
From Investments Rs m-222-26 848.3%  
From Financial Activity Rs m244-64 -379.7%  
Net Cashflow Rs m436 10.3%  

Share Holding

Indian Promoters % 47.1 20.0 235.8%  
Foreign collaborators % 4.2 51.5 8.1%  
Indian inst/Mut Fund % 0.1 0.1 92.9%  
FIIs % 0.1 0.1 92.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 28.5 171.2%  
Shareholders   15,060 4,005 376.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs CORAL LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs CORAL LAB. Share Price Performance

Period BAL PHARMA CORAL LAB. S&P BSE HEALTHCARE
1-Day -4.40% -3.68% 1.18%
1-Month -17.76% 2.65% -0.75%
1-Year 40.93% 65.07% 61.82%
3-Year CAGR 19.04% 4.80% 18.16%
5-Year CAGR 5.43% 3.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the CORAL LAB. share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of CORAL LAB. the stake stands at 71.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of CORAL LAB..

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

CORAL LAB. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of CORAL LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.